Scienceblogtwo

Researchers involved in a new multi-site international phase III study led by Northwestern Medicine found that the drug was highly effective in reducing the signs and symptoms of moderate-to-severe eczema. This is the first study to treat moderate-to-severe eczema in infants and children 6 months to 5 years of age with a biologic drug (monoclonal antibody) instead of immune-suppressing medications. More than half the children experienced at least a 75% reduction in eczema symptoms, highly significant reductions in itching, and improved sleep after a 16-week course of dupilumab, a drug that targets a crucial immunological system in allergens. This is the first massive, random, placebo-controlled trial of a monoclonal antibody for any skin condition, including eczema, in kids as young as six months. The study, which covered 31 locations across Europe and North America, will be released in The Lancet on September 15. According to the lead study author Dr. Amy Paller, chair of dermatology ...

90% of people's lives are often spent indoors, either at work, home, or when traveling. Residents of these enclosed spaces are exposed to a wide range of chemicals from numerous sources, including indoor infiltration of outdoor pollutants, gaseous emissions from furnishings and building materials, and byproducts of our own activities like cooking and cleaning. Additionally, through our breath and skin, we are powerful mobile emission sources of chemicals that enter indoor air. However, how do the chemicals return? This occurs to some extent naturally on its own, when it rains, and through chemical oxidation in the atmosphere outside. In great part, hydroxyl (OH) radicals are in charge of this chemical cleanup. These highly reactive chemicals, also known as the detergents of the atmosphere, are largely created when sunlight reacts with ozone and water vapor to make these very reactive molecules. Direct sunlight and rain have obviously much less of an impact on the air within. Since ...

When exposed to foods that trigger their allergies, many people only have minor symptoms. Some, though, could suffer deadly consequences. In laboratory testing, the bacterial chemical butyrate, which healthy microbiomes produce, has showed promise in preventing allergic reactions. The issue is that it tastes bad when consumed orally. Today, researchers outline a more appealing method of administering this substance. Additionally, they claim that their "polymeric micelles" successfully treat mouse peanut allergies. One day, the medication might be able to treat various inflammatory disorders including food allergies. The researchers will present their findings at the American Chemical Society's fall meeting (ACS). August 21–25 will see the hybrid ACS Fall 2022 meeting, with on-demand access available from August 26–September 9. Nearly 11,000 talks covering a wide range of science issues are included in the meeting. The gut microbiome is made up of bacteria, some of which c...

Numerous significant molecules implicated in anaphylaxis to mammalian meat have had their structures elucidated, paving the way for potential future therapies. Scientists have discovered the genetic and molecular makeup of certain important components linked to the potentially lethal mammalian-meat allergy brought on by tick bites. The study, which was conducted by scientists at the Garvan Institute of Medical Research, explains how antibodies interact with the sugar molecule galactose-1,3-galactose (alpha-gal/alpha-gal), which is produced by all mammals with the exception of humans and higher primates. It adds credence to the idea that the main chemical in this specific allergy is -gal. When some tick species, such as the endemic paralysis tick Ixodes holocyclus of Eastern Australia, bite individuals and transmit -gal, the immune system may perceive the exposure as hazardous and set off an allergic reaction, which can occasionally be fatal. Daniel Christ, a professor, studies the stru...